PARP Inhibition with Rucaparib Alone Followed by Combination with Atezolizumab: Phase Ib COUPLET Clinical Study in Advanced Gynaecological and Triple-Negative Breast Cancers
British journal of cancer（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined